Dr. Aranda is an top expert in the area of pharmacology in the pediatric population. His issue has knowledgeable authors presenting clinical reviews on a wide variety of topics, from "hot areas " of drug therapy to drug abuse in children as well as current areas of debate in neonatal drug therapy. Articles are devoted to the following topics: New and Current Drug Therapies For Asthma In Children; Psychopharmacology Of Bipolar Disorders in Children and Adolescents; Designer Drug Abuse in School Children; Dietary Supplements in Children; Anticoagulant Therapies in Children; New Antimicrobials for Gram-Positive Infections in Children; Probiotics in Newborns And Children; Anticonvulsant Therapies in Newborns and Children; Immunomodulator Drug Therapies in Inflammatory Bowel Diseases in Children; Non-Steroidal Anti-Inflammatory Drugs in Newborns and Children; Metformin Use in Pre-Diabetic Children and Adolescents; Problems in Drug Dosing of Obese Children; Inhaled Drugs and Systemic Steroids for Bronchopulmonary Dysplasia; Antifungal Drugs in Newborns and Children; Antiviral Drugs In Newborns and Children; and Development of Drug Therapies for Newborns and Children. Readers will come away with the latest clinical information to help inform them when diagnosing and prescribing for children.
In this issue of Pediatric Clinics of North America, guest editors Drs. Mary Lieh-Lai and Katherine Cashen bring their considerable expertise to the topic of Pediatric Critical Care.
Laura E Schanberg, MD, Yukiko Kimura, MD. outcomes. For example, in one small mixed methods study of youth with cSLE or mixed connective tissue disease, there was an association between lower socioeconomic status and both poor ...
NIC and NOC codes make possible the collection of electronic data for the purposes of research and reimbursement. Nursing Care Plan 1-1 includes NIC and NOC entries to demonstrate how they are incorporated into the typical care plan.
Romano A, Torres MJ, Castells M, et al. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 2011;127(Suppl 3):S67–73. Hanly LN, Chen N, Aleksa K, et al. N-acetylcysteine as a novel prophylactic treatment ...
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sung-Yun Pai and Nirali N. Shah bring their considerable expertise to the topic of Gene-Based Therapies for Pediatric Blood Diseases.
Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2005;115(4):868–72. 48. Alahmadi YM, Aldeyab MA, McElnay JC, et al. Clinical and economic impact of contaminated blood ...
In A.A. Fanaroff, and J.M. Fanaroff (Eds.): Klaus & Fanaroff's care of the high-risk neonate (6th ed.). Philadelphia, 2013, Elsevier Saunders, pp. 368–409. Rezaee, R.L., Lappen, J.R., and Gecsi, K.S.: Antenatal and intrapartum care of ...
Primary Care Providers and Complementary and Alternative Therapies Patient interest has far outpaced the resources of the traditional health care system; standard texts and reference books do not cover herbs, ...
Medical Clinics of North America, 98, 981–1005. https://doi.org/10.1016/j.mcna.2014.06.013. ... Creswell, C., Waite, P., & Cooper, P. J. (2014). ... Biochemical Pharmacology, 95(2), 81–97. https://doi.org/10.1016/j.bcp.2015.03.011.
KEYWORDS Restless legs syndrome Therapy Treatment Pharmacologic Nonpharmacologic Augmentation KEY POINTS There is limited ... and disappears with the movement of the legs.1 It occurs in 5% to 15% of European and North American adults, ...